Page 3 - Zydus Cadila

Expert panel recommends EUA for Zydus' three-dose Covid vaccine: Report

The committee added that Zydus needs to submit additional data for the 2-dose regimen of its vaccine, say sources

Zydus Cadila gets tentative approval from USFDA for cancer drug

Shares of Cadila Healthcare, the listed entity of the group closed at Rs 531.35 per scrip on BSE, down 0.10 percent from its previous close.

Zydus Cadila Q1 consolidated net profit up 30% to Rs 587 cr

Revenue from operations up 14% to Rs 3,917 crore from Rs 3,424 crore in Q1F21

Zydus Cadila's Covid jab likely to get emergency use approval this week

Ahmedabad-based Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D is expected to get an emergency-use nod from the expert committee this week, sources said

India Covid Dispatch: Zydus Cadila's vaccine may get the nod soon

28% people in TN above 60 yrs show vaccine hesitancy, fully vaccinated people can commute by Mumbai locals from Aug 15 and other stories from around the country on the fight against the pandemic

India may soon have Covid-19 vaccines for children. All you need to know

Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above

Covid-19 vaccine for children likely in August: Health minister Mandaviya

Zydus Cadila has done trials on 12-plus; Bharat Biotech conducting trials on two-plus

Zydus Cadila gets tentative approval from USFDA to market cancer drug

Drug firm Zydus Cadila on Wednesday said it has received tentative approval from the US health regulator to market Ibrutinib tablets used in the treatment of certain types of cancers.

Zydus Cadila plans to start vaccine trials on children above 5 yrs soon

Review of company's Covid vaccine candidate, ZyCoV-D, may be taken up by the SEC this week

Cadila arm completes sale of animal health business for Rs 2,921 crore

Cadila Healthcare on Thursday said its wholly-owned subsidiary Zydus Animal Health and Investment has completed sale of its animal healthcare established markets

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Zydus gets USFDA nod to market generic HIV infection treatment tablets

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad

Zydus' Covid-19 vaccine shows 66.6% efficacy, seeks DCGI approval

Phase 3 trial for the vaccine had more than 28,000 volunteers-the largest such exercise in India, says company.

Zydus Cadila aims to produce 10 million Covid vaccine doses per month

Zydus claims 66.6 per cent efficiency against symptomatic Covid cases and 100 per cent for moderate disease.

Zydus Cadila seeks emergency use approval for Covid vax for 12 years, above

Zydus Cadila applied for Emergency Use Authorisation seeking approval from the Drugs Controller General of India for the launch of their ZyCoV-D vaccine for 12 years and above

Blurred picture

The sharp cuts in vaccine supply projections are baffling

Zydus Covid-19 vaccine doses may be out soon for adolescents: Govt

Says 1.35 bn doses will be available between Aug-Dec; 160 mn doses are expected between May and July

Zydus Cadila likely to seek EUA for its ZyCoV-D vaccine in 7-8 days

It will be the second indigenous Covid-19 vaccine to apply for such authorisation. It will also be the world's first DNA vaccine against coronavirus

Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug

Zydus Cadila on Monday said it has received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets.

Zydus Cadila may soon seek emergency use authorisation for Covid-19 vaccine

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator